News
Despite disappointing results during the first quarter, experts continue to have a positive outlook on ICON Public Limited ...
Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today reported financial ...
Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company , known for its bold flavors and unfiltered wheat ales, today announced a transformative rebrand. With revamped packaging, a new ...
I recently bought a pack of Orbit mint gum from the library vending machine. On the edge of the packet, it said: “40% fewer ...
The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global prevalence of chronic illnesses like diabet ...
Fortrea forecasts revenue and EBITDA declines for 2025. With a $477.16M market cap, financial improvement could drive stock ...
Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...
To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward ...
A special CBI court here on Tuesday convicted former Karnataka minister and MLA Gali Janardhan Reddy and three others in the ...
Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their ...
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $202.5 million in its first quarter. On a per-share basis, the Salt Lake City-based ...
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $64.1 million in its first quarter. On a per-share basis, the Bedford, Massachusetts-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results